Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Today, the U.S. Food and Drug Administration approved emergency use of the bivalent Moderna COVID-19 vaccine booster, and the bivalent Pfizer-BioNTech COVID-19 booster, for younger age groups.

The head of the World Health Organization, Tedros Adhanom Ghebreyesus, announced a clinical trial for a vaccine to fight the current Ebola outbreak in Uganda. In that country there are now 19 confirmed Ebola fatalities and 54 cases. (Reuters)

NPR's Morning Edition explores how artificial intelligence may assist in diagnosing illness based on collected voice data. The National Institutes of Health is funding this research as part of its $100 million Bridge to AI program.

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!

‍

‍

Our Culture

“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”

‍      –Jess, Program Manager

‍‍

‍

‍

About Judi

Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.